Covishield

COVID-19 vaccine update: SII, ICMR complete enrolment of phase-3 clinical trials of COVISHIELD

COVID-19 vaccine update: SII, ICMR complete enrolment of phase-3 clinical trials of COVISHIELD

Serum Institute of India (SII) and the Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of pha...Read More

COVID-19 in Mumbai: KEM Hospital begins Covishield phase 2 trial

COVID-19 in Mumbai: KEM Hospital begins Covishield phase 2 trial

The much awaited clinical trial of the COVID-19 vaccine Covishield developed by the University of Oxford began at the King Edward Memoria...Read More

3 volunteers to get 1st shot of vaccine; Covishield human trials at KEM today

3 volunteers to get 1st shot of vaccine; Covishield human trials at KEM today

Three volunteers will be administered the first doses of 'Covishield', the potential Covid-19 vaccine at the King Edward Memorial (KEM) h...Read More

Coronavirus in Mumbai: KEM Hospital starts trials of Covishield vaccine

Coronavirus in Mumbai: KEM Hospital starts trials of Covishield vaccine

The civic-run King Edward Memorial (KEM) Hospital in Mumbai on Wednesday began phase II and III trials of the Oxford Covishield vaccine f...Read More

Adar Poonawalla breaks silence on SII -Covishield clinical trials; says 'stay patient for two months'

Adar Poonawalla breaks silence on SII -Covishield clinical trials; says 'stay patient for two months'

On Thursday, Serum Institute of India CEO Adar Poonawalla asked the media to refrain from reporting on data coming in about patients on S...Read More

Phase II human trial of Oxford vaccine begins in Pune

Phase II human trial of Oxford vaccine begins in Pune

The Phase II clinical trial of the Oxford COVID-19 vaccine, being manufactured by the city-based Serum Institute of India (SII), began at...Read More

Adar Poonwalla's big risk: If Oxford vaccine Covishield dwindles, Serum Institute may lose whopping Rs 1,492 crore

Adar Poonwalla's big risk: If Oxford vaccine Covishield dwindles, Serum Institute may lose whopping Rs 1,492 crore

At this time of the pandemic, many businesses have taken some risky decisions to remain afloat. But Cyrus Poonawalla-founded Serum Instit...Read More

Free Press Journal

www.freepressjournal.in